Pfizer (PFE) FY2021 results: revenue $81.3 billion, up 95.2% on the year
Pfizer Inc. (PFE) reported revenue of $81.3 billion for fiscal 2021, the year ended 31 December 2021, up 95.2% on the year before. Net income was $22.0 billion, up 140.0%, and diluted earnings per share $3.85. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2023.
Revenue
$81.3 billion
+95.2% on the year
FY2014FY2021
Operating margin
n/a
FY2014FY2021
Net income
$22.0 billion
+140.0% on the year
FY2014FY2021
Diluted EPS
$3.85
+136.2% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
32,580
14,403
12,588
+126.2%
Capital expenditure
2,711
2,226
2,046
+21.8%
Free cash flow
29,869
12,177
10,542
+145.3%
Free cash flow margin
36.7%
29.2%
25.8%
Cash from investing
-22,546
-4,271
-3,945
Cash from financing
-9,816
-9,649
-8,485
Depreciation and amortisation
5,191
4,681
5,755
+10.9%
Share-based compensation
1,182
756
687
+56.3%
Buybacks
0.0
0.0
8,865
Dividends paid
8,729
8,440
8,043
+3.4%
Dividend per share
$1.57
$1.53
$1.46
+2.6%
Diluted shares, weighted
5,708m
5,632m
5,675m
+1.3%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
77,201
63,238
63,143
+22.1%
Non-controlling interest
262
235
303
+11.5%
Debt
38,436
39,836
52,150
-3.5%
Operating lease liabilities
2,510
1,108
1,030
+126.5%
Other liabilities
63,067
49,812
50,863
+26.6%
Total liabilities and equity
181,476
154,229
167,489
+17.7%
Fixed assets
14,882
13,745
12,969
+8.3%
Goodwill
49,208
49,577
48,181
-0.7%
Intangible assets
25,146
28,337
33,936
-11.3%
Investments
43,540
30,699
28,672
+41.8%
Cash and equivalents
1,944
1,784
1,121
+9.0%
Receivables
11,479
7,913
6,772
+45.1%
Inventory
9,059
8,020
7,068
+13.0%
Other assets
26,218
14,154
28,770
+85.2%
Total assets
181,476
154,229
167,489
+17.7%
10-K for the year ended 31 December 2021, filed 23 February 2023: the filing.